Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 39 announcements

Share price: ₹224.52
Market cap: ₹2,768 Cr
Revenue (annual): ₹1,713 Cr
Net profit (annual): ₹-48.80 Cr
P/E (TTM): -553.7×Sector 43.8×
Promoter holding: 68.85%+0.00% QoQ
FII holding: 1.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 7 Earnings Call 7 Management Change 4 Financial Results 4 Annual General Meeting 4 Results Update 3 Board Meeting Date 3 Results Correction 1 Regulatory Approval 1 Production Started 1 New Order Win 1 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Apr 2026 16:33 IST NSE

Results Correction

Hikal Results Correction

Hikal Limited clarified an inadvertent error in its XBRL filing for the quarter ended September 30, 2025. EPS figures were mistakenly reported under discontinued operations instead of continuing operations. The company confirmed that the PDF filing was correct, showing quarterly EPS of Rs. (2.81) and year-to-date EPS of Rs. (4.65).

Open announcement → Read the filing ↗